A key element of NCCR AntiResist is the effective translation of discoveries and novel tools created within the scope of our research to clinical practice and to drug development in the private sector. Our dynamic strategy for knowledge and technology-transfer (KTT) promotes technology-transfer, supports identification of intellectual property (IP) and encourages entrepreneurship by fostering and promoting spin-off companies from AntiResist activities.
The Knowledge-and-Technology-Transfer Office is your contact point if you are considering starting your own company based on innovation from the AntiResist program.
Further, promoting joint projects with companies and short research stays for PhD students, as well as integrating speakers from industry into the curriculum of the newly designed PhD school HIB is an integral part of the KTT strategy. Technology transfer to private partners and start-up companies will be handled in collaboration with the Technology Transfer Offices of the participating Institutions, such as Unitectra, the Switzerland-wide technology-transfer agency servicing the Universities of Basel, Zürich and Bern, and ETH Transfer.
In line with this role, together with the Education-and-Training Officer and the Communication Officer, the KTT Office will organize extra-curricular training on IP and knowledge transfer.
These activities will be coordinated under the leadership of a dedicated KTT Officer, Dr Helmut Kessmann.